Novavax, a biotech company focused on developing vaccines against infectious diseases, announced Monday that it is beginning a phase 1 clinical trial of its Covid-19 vaccine candidate in Australia. Results of the trial are expected in July 2020.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,